CORC  > 暨南大学
Glioma Patients Derive Any Therapeutic Benefit From Taking a Higher Cumulative Dose of Temozolomide Regimens? A Meta-Analysis
Sun, Hao[1]; Du, Shasha[1]; Liao, Guixiang[1,2]; Xie, Xiao[3]; Ren, Chen[1]; Yuan, Ya Wei[1]
2015
卷号94期号:20
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4291616
专题暨南大学
作者单位1.[1]Southern Med Univ, Dept Radiat Oncol, Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China
2.[2]Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China
3.[3]Southern Med Univ, Zhujiang Hosp, Dept Rehabil, Guangzhou 510515, Guangdong, Peoples R China
推荐引用方式
GB/T 7714
Sun, Hao[1],Du, Shasha[1],Liao, Guixiang[1,2],et al. Glioma Patients Derive Any Therapeutic Benefit From Taking a Higher Cumulative Dose of Temozolomide Regimens? A Meta-Analysis[J],2015,94(20).
APA Sun, Hao[1],Du, Shasha[1],Liao, Guixiang[1,2],Xie, Xiao[3],Ren, Chen[1],&Yuan, Ya Wei[1].(2015).Glioma Patients Derive Any Therapeutic Benefit From Taking a Higher Cumulative Dose of Temozolomide Regimens? A Meta-Analysis.,94(20).
MLA Sun, Hao[1],et al."Glioma Patients Derive Any Therapeutic Benefit From Taking a Higher Cumulative Dose of Temozolomide Regimens? A Meta-Analysis".94.20(2015).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace